Search at Vanderbilt-Ingram Cancer Center

1059 results found

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Relevance: 1

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

Relevance: 1

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

Relevance: 1

Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

Relevance: 1

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS1, hrHPV+ Oropharyngeal Cancer

Relevance: 1

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Relevance: 1

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Relevance: 1

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Relevance: 1

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Relevance: 1

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

Relevance: 1